Guilherme Nader Marta, Clinical Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“Honoured to share our article in the NEJM Group Breast Cancer Update discussing two perspectives on anthracycline use in breast cancer—a long-debated topic that remains highly relevant today.
Grateful to co-author this work with Martine Piccart.”
